PETX
Aratana Therapeutics, Inc.
PETX
PETX
Delisted
PETX was delisted on the 17th of July, 2019.
81 hedge funds and large institutions have $396M invested in Aratana Therapeutics, Inc. in 2014 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 31 increasing their positions, 9 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
81
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$29.1M | |
| 2 | +$15.4M | |
| 3 | +$15.3M | |
| 4 |
DM
Deerfield Management
New York
|
+$14.6M |
| 5 |
BC
Broadfin Capital
New York
|
+$12.4M |
Top Sellers
| 1 | -$29M | |
| 2 | -$10.9M | |
| 3 | -$1.86M | |
| 4 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$322K |
| 5 |
JPMorgan Chase & Co
New York
|
-$226K |